• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

室间隔厚度是否影响肥厚型梗阻性心肌病心肌切除术的疗效?

Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy?

机构信息

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

出版信息

Eur J Cardiothorac Surg. 2018 Mar 1;53(3):582-589. doi: 10.1093/ejcts/ezx398.

DOI:10.1093/ejcts/ezx398
PMID:29182736
Abstract

OBJECTIVES

Patients with hypertrophic obstructive cardiomyopathy and basal septal thickness <18 mm are often considered unsuitable candidates for myectomy. Mitral valve (MV) replacement is frequently performed instead. We aimed to determine whether septal thickness affects outcomes and adequacy of myectomy.

METHODS

Clinical and echocardiographic data were reviewed for 1486 consecutive adult patients with hypertrophic obstructive cardiomyopathy who underwent transaortic septal myectomy from January 2005 through December 2014. Comparisons between patients, grouped by septal thickness (<18 mm, n = 369; 18-21 mm, n = 612 and >21 mm, n = 505), were performed with the Kruskal-Wallis and the Pearson χ2 tests and semiparametric analysis of covariance.

RESULTS

Median group ages were 57, 57 and 54 years (P = 0.007); men comprised 50.4%, 56.7% and 62.0%, respectively (P = 0.003). Intrinsic MV disease was present in 5.9%, 5.2% and 4.6%, respectively (P = 0.80). All patients underwent transaortic septal myectomy. Additional mitral procedures were performed in 7.6%, 7.8% and 8.1%, respectively (P = 0.90). Reasons for MV surgery included intrinsic MV disease (66.7%), residual mitral regurgitation (30.8%) and residual gradient (2.6%). All groups had postoperative gradient relief (median reduction: 51, 54 and 50 mmHg; P = 0.11). Ventricular septal defect occurred in 4 patients (0.3%), and risk did not differ by group (P = 0.24).

CONCLUSIONS

Adequate relief of left ventricular outflow tract obstruction can be achieved via transaortic septal myectomy without concomitant MV procedures when septal thickness is < 18 mm, and the risk of ventricular septal defect is minimal. Concomitant MV repair/replacement should be reserved for patients with intrinsic MV disease or inadequate relief of mitral regurgitation/left ventricular outflow tract obstruction following adequate extended septal myectomy.

摘要

目的

对于室间隔厚度<18mm 的肥厚型梗阻性心肌病患者,通常认为其不适合进行心肌切除术。因此,常施行二尖瓣置换术。本研究旨在确定室间隔厚度是否会影响心肌切除术的结果和充分性。

方法

回顾性分析 2005 年 1 月至 2014 年 12 月期间,1486 例接受经主动脉室间隔切除术的成人肥厚型梗阻性心肌病患者的临床和超声心动图数据。通过 Kruskal-Wallis 和 Pearson χ2 检验以及半参数协方差分析,比较按室间隔厚度(<18mm,n=369;18-21mm,n=612;>21mm,n=505)分组的患者。

结果

中位年龄分别为 57、57 和 54 岁(P=0.007);男性比例分别为 50.4%、56.7%和 62.0%(P=0.003)。固有二尖瓣病变的比例分别为 5.9%、5.2%和 4.6%(P=0.80)。所有患者均接受经主动脉室间隔切除术,分别有 7.6%、7.8%和 8.1%的患者接受附加二尖瓣手术(P=0.90)。二尖瓣手术的原因包括固有二尖瓣病变(66.7%)、残余二尖瓣反流(30.8%)和残余梯度(2.6%)。所有组的术后梯度均得到缓解(中位数降幅:51、54 和 50mmHg;P=0.11)。4 例(0.3%)患者发生室间隔缺损,各组间风险无差异(P=0.24)。

结论

当室间隔厚度<18mm 时,经主动脉室间隔切除术可充分缓解左心室流出道梗阻,且发生室间隔缺损的风险极小。当充分延长室间隔切除后仍存在固有二尖瓣病变或二尖瓣反流/左心室流出道梗阻未充分缓解时,应保留二尖瓣修复/置换术。

相似文献

1
Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy?室间隔厚度是否影响肥厚型梗阻性心肌病心肌切除术的疗效?
Eur J Cardiothorac Surg. 2018 Mar 1;53(3):582-589. doi: 10.1093/ejcts/ezx398.
2
Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.经主动脉瓣腱索切断术治疗合并轻度室间隔肥厚的梗阻性肥厚型心肌病所致二尖瓣关闭不全
J Am Coll Cardiol. 2015 Oct 13;66(15):1687-96. doi: 10.1016/j.jacc.2015.07.069.
3
Septal Myectomy With Vs Without Subvalvular Apparatus Intervention in Patients With Hypertrophic Obstructive Cardiomyopathy: A Prospective Randomized Study.肥厚型梗阻性心肌病患者行室间隔心肌切除术伴或不伴瓣下结构介入的前瞻性随机研究。
Semin Thorac Cardiovasc Surg. 2019 Autumn;31(3):424-431. doi: 10.1053/j.semtcvs.2019.01.011. Epub 2019 Jan 11.
4
Minimally invasive septal myectomy for the treatment of hypertrophic obstructive cardiomyopathy and intrinsic mitral valve disease.微创间隔心肌切除术治疗肥厚型梗阻性心肌病和原发性二尖瓣疾病。
Innovations (Phila). 2015 Mar-Apr;10(2):106-13. doi: 10.1097/IMI.0000000000000132.
5
Hypertrophic cardiomyopathy with moderate septal thickness and mitral regurgitation: long-term surgical results.肥厚型心肌病伴中度室间隔增厚和二尖瓣反流:长期手术结果。
Eur J Cardiothorac Surg. 2021 Jul 30;60(2):244-251. doi: 10.1093/ejcts/ezab097.
6
Individualized surgical strategies for left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.肥厚型心肌病患者左心室流出道梗阻的个体化手术策略。
Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1237-1243. doi: 10.1093/ejcts/ezx458.
7
Mitral stenosis and hypertrophic obstructive cardiomyopathy: An unusual combination.二尖瓣狭窄和肥厚型梗阻性心肌病:一种不常见的组合。
J Thorac Cardiovasc Surg. 2016 Apr;151(4):1044-8. doi: 10.1016/j.jtcvs.2015.11.048. Epub 2015 Dec 8.
8
Is anterior mitral valve leaflet length important in outcome of septal myectomy for obstructive hypertrophic cardiomyopathy?二尖瓣前叶长度对梗阻性肥厚型心肌病室间隔心肌切除术的预后是否重要?
J Thorac Cardiovasc Surg. 2023 Jan;165(1):79-87.e1. doi: 10.1016/j.jtcvs.2020.12.143. Epub 2021 Jan 21.
9
Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.无严重室间隔肥厚的肥厚型心肌病患者的左心室流出道梗阻:利用心脏磁共振成像和超声心动图评估二尖瓣和乳头肌异常的意义
Circ Cardiovasc Imaging. 2015 Jul;8(7):e003132. doi: 10.1161/CIRCIMAGING.115.003132.
10
Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae.对于合并二尖瓣乳头肌或腱索异常的肥厚型梗阻性心肌病行扩大室间隔心肌切除术。
J Thorac Cardiovasc Surg. 2004 Feb;127(2):481-9. doi: 10.1016/j.jtcvs.2003.09.040.

引用本文的文献

1
Supravalvular aortic stenosis mimicking hypertrophic obstructive cardiomyopathy: a case report.酷似肥厚型梗阻性心肌病的瓣上主动脉狭窄:一例报告
Eur Heart J Case Rep. 2025 Jun 28;9(7):ytaf312. doi: 10.1093/ehjcr/ytaf312. eCollection 2025 Jul.
2
Obstructive hypertrophic cardiomyopathy: from genetic insights to a multimodal therapeutic approach with mavacamten, aficamten, and beyond.梗阻性肥厚型心肌病:从基因洞察到马伐卡坦、阿非卡坦及其他药物的多模式治疗方法
Egypt Heart J. 2024 Dec 7;76(1):156. doi: 10.1186/s43044-024-00587-y.
3
A systematic review of present and future pharmaco-structural therapies for hypertrophic cardiomyopathy.
肥厚型心肌病的现有和未来药物结构治疗的系统评价。
Clin Cardiol. 2024 Jan;47(1):e24207. doi: 10.1002/clc.24207.
4
Association of Preoperative Sleep-Disordered Breathing With Functional Status After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.术前睡眠呼吸障碍与梗阻性肥厚型心肌病行室间隔心肌切除术后功能状态的关联
CJC Open. 2022 Jul 11;4(10):848-853. doi: 10.1016/j.cjco.2022.06.010. eCollection 2022 Oct.
5
Septal Thickness Does Not Impact Outcome After Hypertrophic Obstructive Cardiomyopathy Surgery (Septal Myectomy and Subvalvular Mitral Apparatus Remodeling): A 15-Years of Experience.间隔厚度对肥厚性梗阻性心肌病手术(间隔心肌切除术和瓣膜下二尖瓣装置重塑)后的结果无影响:15年经验总结
Front Cardiovasc Med. 2022 Jun 15;9:853582. doi: 10.3389/fcvm.2022.853582. eCollection 2022.
6
Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive Cardiomyopathy: State-of-the-Art Review.肥厚型梗阻性心肌病当代侵入性治疗方法综述及指南批判性评价:最新进展综述
J Clin Med. 2022 Jun 14;11(12):3405. doi: 10.3390/jcm11123405.
7
Midterm Outcome After Septal Myectomy and Medical Therapy in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy.轻度症状性肥厚性梗阻性心肌病患者行室间隔心肌切除术后及药物治疗的中期结果
Front Cardiovasc Med. 2022 Mar 25;9:855491. doi: 10.3389/fcvm.2022.855491. eCollection 2022.
8
Targeting Alcohol Septal Ablation in Patients with Obstructive Hypertrophic Cardiomyopathy Candidates for Surgical Myectomy: Added Value of Three-Dimensional Intracoronary Myocardial Contrast Echocardiography.针对拟行外科心肌切除术的梗阻性肥厚型心肌病患者的酒精间隔消融术:三维冠状动脉内心肌对比超声心动图的附加价值
J Clin Med. 2021 May 17;10(10):2166. doi: 10.3390/jcm10102166.
9
Surgical outcome for hypertrophic cardiomyopathy patients with extreme interventricular septal thickness: a propensity score matched study.伴有极度室间隔增厚的肥厚型心肌病患者的手术结局:一项倾向评分匹配研究
J Thorac Dis. 2020 Oct;12(10):5460-5467. doi: 10.21037/jtd-20-1705.
10
Management of the mitral valve in patients with obstructive hypertrophic cardiomyopathy.梗阻性肥厚型心肌病患者二尖瓣的管理
Indian J Thorac Cardiovasc Surg. 2020 Jan;36(Suppl 1):34-43. doi: 10.1007/s12055-019-00817-y. Epub 2019 May 7.